Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CAN compared with TBPH: revenue, margins and what each company keeps, and the suppliers and customers both name
CAN
Canaan Inc.
Change
Mkt cap
Revenue
Revenue
TBPH
Theravance Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CAN
Canaan Inc.
vs
TBPH
Theravance Biopharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CAN, solid
TBPH, dashed
Supply-chain overlap
Revenue flow
CAN: latest quarter not drawable. TBPH: latest quarter is a loss; flow not drawable.
Method
›
CAN
Canaan Inc.
Change
0.20
▼
−12.00%
· post 0.20
Mkt cap
$143.6M
Revenue
—
Revenue
—
TBPH
Theravance Biopharma, Inc.
Change
17.03
▲
+0.02%
· post 17.04
Closed
Oct 30 '26
Mkt cap
$884.2M
Revenue
$21M
Q2 FY26
Revenue
$107M
FY25
vs
Compare
Closed
Oct 30 '26
CAN
Canaan Inc.
vs
TBPH
Theravance Biopharma, Inc.
0.20
▼
−12.00%
post 0.20
Price
17.03
▲
+0.02%
post 17.04
$143.6M
Mkt cap
$884.2M
—
Revenue
$21M
Q2 FY26
—
Revenue
$107M
FY25
Change
Change
CAN
0.20
▼
−12.00%
vs
TBPH
17.03
▲
+0.02%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CAN
0
None
Shared
0
No disclosed counterparties: CAN.
Only TBPH
6
VTRS
Viatris
supplier
LAZ
Lazard
supplier
GSK
GSK
customer
RPRX
Royalty Pharma Investments
customer
2 more · TBPH chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR